New York State Teachers Retirement System Trims Stake in West Pharmaceutical Services Inc. (WST)

New York State Teachers Retirement System decreased its holdings in shares of West Pharmaceutical Services Inc. (NYSE:WST) by 1.6% in the 1st quarter, HoldingsChannel reports. The firm owned 106,339 shares of the medical instruments supplier’s stock after selling 1,700 shares during the period. New York State Teachers Retirement System’s holdings in West Pharmaceutical Services were worth $11,719,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Raymond James & Associates lifted its position in shares of West Pharmaceutical Services by 4.9% in the first quarter. Raymond James & Associates now owns 46,683 shares of the medical instruments supplier’s stock worth $5,145,000 after purchasing an additional 2,169 shares in the last quarter. Trillium Asset Management LLC lifted its position in shares of West Pharmaceutical Services by 64.6% in the first quarter. Trillium Asset Management LLC now owns 19,433 shares of the medical instruments supplier’s stock worth $2,142,000 after purchasing an additional 7,626 shares in the last quarter. First Allied Advisory Services Inc. purchased a new stake in shares of West Pharmaceutical Services in the first quarter worth approximately $327,000. TAP Consulting LLC bought a new position in West Pharmaceutical Services during the first quarter valued at approximately $1,869,000. Finally, Stephens Inc. AR raised its position in West Pharmaceutical Services by 13.5% during the first quarter. Stephens Inc. AR now owns 3,210 shares of the medical instruments supplier’s stock valued at $354,000 after acquiring an additional 383 shares in the last quarter. Institutional investors own 94.44% of the company’s stock.

In other West Pharmaceutical Services news, VP Daniel Malone sold 4,458 shares of the stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $123.03, for a total transaction of $548,467.74. Following the transaction, the vice president now owns 33,478 shares in the company, valued at $4,118,798.34. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Company insiders own 1.70% of the company’s stock.



Shares of WST opened at $118.53 on Wednesday. The company has a market cap of $8.63 billion, a P/E ratio of 42.18, a price-to-earnings-growth ratio of 3.54 and a beta of 1.29. The company has a debt-to-equity ratio of 0.19, a quick ratio of 2.13 and a current ratio of 2.88. West Pharmaceutical Services Inc. has a twelve month low of $89.55 and a twelve month high of $125.09.

West Pharmaceutical Services (NYSE:WST) last issued its quarterly earnings data on Thursday, April 25th. The medical instruments supplier reported $0.74 earnings per share for the quarter, beating the consensus estimate of $0.66 by $0.08. The firm had revenue of $443.50 million for the quarter, compared to analyst estimates of $431.00 million. West Pharmaceutical Services had a net margin of 12.53% and a return on equity of 16.38%. The company’s revenue for the quarter was up 6.7% on a year-over-year basis. During the same quarter last year, the firm earned $0.62 earnings per share. Analysts predict that West Pharmaceutical Services Inc. will post 2.87 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Wednesday, August 7th. Shareholders of record on Wednesday, July 24th will be issued a dividend of $0.15 per share. The ex-dividend date of this dividend is Tuesday, July 23rd. This represents a $0.60 annualized dividend and a yield of 0.51%. West Pharmaceutical Services’s dividend payout ratio (DPR) is presently 21.35%.

Several equities analysts recently weighed in on WST shares. William Blair started coverage on shares of West Pharmaceutical Services in a research report on Tuesday, April 23rd. They set an “outperform” rating and a $112.16 price objective on the stock. Jefferies Financial Group lowered shares of West Pharmaceutical Services from a “buy” rating to a “hold” rating and set a $122.00 price objective on the stock. in a research report on Wednesday, May 1st. Finally, Zacks Investment Research lowered shares of West Pharmaceutical Services from a “hold” rating to a “sell” rating in a research report on Saturday, April 27th.

TRADEMARK VIOLATION WARNING: “New York State Teachers Retirement System Trims Stake in West Pharmaceutical Services Inc. (WST)” was published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://dakotafinancialnews.com/2019/05/22/new-york-state-teachers-retirement-system-trims-stake-in-west-pharmaceutical-services-inc-wst.html.

West Pharmaceutical Services Company Profile

West Pharmaceutical Services, Inc manufactures and sells containment and delivery systems for injectable drugs and healthcare products in the United States, Germany, France, Other European countries, South Korea, and internationally. The company operates through two segments, Proprietary Products and Contract-Manufactured Products.

See Also: What is the Stochastic Momentum Index (SMI)?

Want to see what other hedge funds are holding WST? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for West Pharmaceutical Services Inc. (NYSE:WST).

Institutional Ownership by Quarter for West Pharmaceutical Services (NYSE:WST)

Receive News & Ratings for West Pharmaceutical Services Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for West Pharmaceutical Services and related companies with MarketBeat.com's FREE daily email newsletter.